Edition:
United Kingdom

TRACON Pharmaceuticals Inc (TCON.OQ)

TCON.OQ on NASDAQ Stock Exchange Global Market

2.05USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
16,960
52-wk High
$3.95
52-wk Low
$2.00

Chart for

About

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is... (more)

Overall

Beta: --
Market Cap(Mil.): $61.63
Shares Outstanding(Mil.): 16.66
Dividend: --
Yield (%): --

Financials

  TCON.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.76 -- --
ROI: -107.08 1.78 14.61
ROE: -146.37 3.28 16.33

BRIEF-Tracon Pharmaceuticals Files For Offering Of Up To 27.4 Mln Shares Of Common Stock By The Selling Stockholders

* TRACON PHARMACEUTICALS INC FILES FOR OFFERING OF UP TO 27.4 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS Source text: [https://bit.ly/2KQef7f] Further company coverage:

10 May 2018

BRIEF-TRACON Pharmaceuticals Reports Qtrly Loss Per Share $0.46

* TRACON PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

09 May 2018

BRIEF-Tracon Pharmaceuticals Says Patricia Bitar Notified That Resigning As Co's CFO

* TRACON PHARMACEUTICALS INC - ON APRIL 30, PATRICIA L. BITAR NOTIFIED THAT RESIGNING AS CO'S CFO, EFFECTIVE JUNE 15, 2018- SEC FILING Source text for Eikon: (https://bit.ly/2w9w9yD) Further company coverage:

04 May 2018

BRIEF-Tracon Pharmaceuticals Says Regarding Election Of Ted Wang To Board, Board Approved Increase In Size From Six To Seven Members

* TRACON PHARMACEUTICALS SAYS REGARDING ELECTION OF TED WANG TO BOARD, BOARD APPROVED AN INCREASE IN SIZE FROM SIX TO SEVEN MEMBERS - SEC FILING Source text: (https://bit.ly/2JBtjFa) Further company coverage:

10 Apr 2018

BRIEF-Linden Capital Reports 9.9 Pct Passive Stake In Tracon Pharmaceuticals

* LINDEN CAPITAL L.P. REPORTS 9.9 PCT PASSIVE STAKE IN TRACON PHARMACEUTICALS INC AS OF MARCH 27, 2018 - SEC FILING Source text: [https://bit.ly/2pZqDIp] Further company coverage:

02 Apr 2018

BRIEF-TRACON Pharmaceuticals Announces $38.7 Million Private Placement

* TRACON PHARMACEUTICALS ANNOUNCES $38.7 MILLION PRIVATE PLACEMENT

23 Mar 2018

BRIEF-TRACON Pharma Qtrly Loss Per Share $0.37

* TRACON PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

28 Feb 2018

Earnings vs. Estimates